The analyst is optimistic about Orthofix Medical's unique offerings and plans for ongoing innovation. 7D and ortho sub-segments are in Orthofix Medical's highest growing markets. Canaccord Genuity ...

Comparatively, Orthofix Medical has a beta of 1.1, meaning that its share price is 10% more volatile than the S&P 500. 99.1% of AtriCure shares are owned by institutional investors. Comparatively ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...